Robin V. G.
- Country
- The Netherlands
- Department
- Clinical Pharmacy and Toxicology
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Oncology – Solid Tumors
Robin van Geel contributes to clinical studies in oncology targeting a broad spectrum of solid malignancies.
- Non‑Small Cell Lung Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Breast Cancer
- Renal Cell Carcinoma
Research emphasizes novel immunotherapies and targeted agents.
Hematology – Blood Cancers
In the field of hematology, the investigator addresses malignant hematologic conditions.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Mantle Cell Lymphoma
- Diffuse Large B‑Cell Lymphoma
Efforts include evaluation of cellular therapies and kinase inhibitors.
Cardiovascular Medicine
Robin van Geel’s work in cardiovascular disease includes acute and chronic heart conditions.
- Acute Coronary Syndrome
- Heart Failure
- Hypertrophic Cardiomyopathy
- Atrial Fibrillation
- Aortic Stenosis
Studies aim to improve outcomes through pharmacologic and device‑based interventions.
Pulmonary & Respiratory Disorders
The investigator participates in research on pulmonary disorders and related critical care.
- Chronic Obstructive Pulmonary Disease
- Acute Respiratory Distress Syndrome
- Small‑Cell Lung Cancer
- Interstitial Lung Disease
- Asthma
Focus is on novel anti‑inflammatory and antiviral strategies.
Neurology & Rare Genetic Disorders
Research activities also span neurology and rare genetic conditions.
- Meniere’s Disease
- Spinocerebellar Ataxia
- Huntington’s Disease
- Transthyretin Amyloidosis
- Genetic Dilated Cardiomyopathy
Investigations target disease‑modifying therapies and biomarkers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.